Skip to main
PHR
PHR logo

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 38%
Buy 62%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia Inc. is projecting total revenue between $472.0 million and $482.0 million for the fiscal year, reflecting a year-over-year growth of approximately 12% to 15%, which positions the company favorably relative to prior consensus expectations. The network solutions segment demonstrated robust performance with revenue reaching $35.2 million, marking a 25% year-over-year growth that exceeded both consensus and internal estimates. Additionally, Phreesia's guidance for fiscal year 2026 indicates a stable outlook, maintaining revenue expectations and improving adjusted EBITDA estimates, signaling strong operational and financial health.

Bears say

Phreesia Inc. is facing downward pressure on its financial outlook due to several key factors. The company anticipates a slight sequential decline in payment processing revenues attributed to seasonality, coupled with broader concerns over a slowdown in organic growth and increased competition within the healthcare software market. Additionally, a non-GAAP gross margin of 68.7% fell short of estimates, highlighting potential inefficiencies, while the overall economic climate raises concerns about spending by providers and payers, further exacerbating financial uncertainties.

Phreesia Inc (PHR) has been analyzed by 13 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 62% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 13 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $33.92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $33.92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.